Randomized double-blind Phase III trial of FOLF(HA)iri vs FOLFIRI for second or third line therapy in irinotecan-naive patients with metastatic colorectal cancer.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Irinotecan hyaluronic acid complex (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Levofolinic acid
- Indications Colorectal cancer
- Focus Registrational; Therapeutic Use
- Sponsors Alchemia Oncology
- 26 Oct 2014 Primary endpoint has not been met (progression-free survival rate), according to an Alchemia media release.
- 26 Oct 2014 Results published in an Alchemia media release.
- 09 Oct 2014 Alchemia has announced a database lock of this pivotal trial for the primary efficacy analysis, and results are expected to be reported by the end of October 2014, according to a media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History